Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1999 Mar;54(3):245–252. doi: 10.1136/thx.54.3.245

Molecular genetics of chronic obstructive pulmonary disease

P Barnes 1
PMCID: PMC1745439  PMID: 10325902

Full Text

The Full Text of this article is available as a PDF (127.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abboud R. T., Yu P., Chan-Yeung M., Tan F. Lack of relationship between ABH secretor status and lung function in pulp mill workers. Am Rev Respir Dis. 1982 Dec;126(6):1089–1091. doi: 10.1164/arrd.1982.126.6.1089. [DOI] [PubMed] [Google Scholar]
  2. Abe T., Kobayashi N., Yoshimura K., Trapnell B. C., Kim H., Hubbard R. C., Brewer M. T., Thompson R. C., Crystal R. G. Expression of the secretory leukoprotease inhibitor gene in epithelial cells. J Clin Invest. 1991 Jun;87(6):2207–2215. doi: 10.1172/JCI115255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Alvarez-Granda L., Cabero-Perez M. J., Bustamante-Ruiz A., Gonzalez-Lamuño D., Delgado-Rodriguez M., García-Fuentes M. PI SZ phenotype in chronic obstructive pulmonary disease. Thorax. 1997 Jul;52(7):659–661. doi: 10.1136/thx.52.7.659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Artlich A., Boysen A., Bunge S., Entzian P., Schlaak M., Schwinger E. Common CFTR mutations are not likely to predispose to chronic bronchitis in northern Germany. Hum Genet. 1995 Feb;95(2):226–228. doi: 10.1007/BF00209408. [DOI] [PubMed] [Google Scholar]
  5. Barnes P. J. Chronic obstructive pulmonary disease: new opportunities for drug development. Trends Pharmacol Sci. 1998 Oct;19(10):415–423. doi: 10.1016/s0165-6147(98)01245-0. [DOI] [PubMed] [Google Scholar]
  6. Barnes P. J., Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med. 1997 Apr 10;336(15):1066–1071. doi: 10.1056/NEJM199704103361506. [DOI] [PubMed] [Google Scholar]
  7. Barnes P. J. New therapies for chronic obstructive pulmonary disease. Thorax. 1998 Feb;53(2):137–147. doi: 10.1136/thx.53.2.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Beaty T. H., Menkes H. A., Cohen B. H., Newill C. A. Risk factors associated with longitudinal change in pulmonary function. Am Rev Respir Dis. 1984 May;129(5):660–667. doi: 10.1164/arrd.1984.129.5.660. [DOI] [PubMed] [Google Scholar]
  9. Björkander J., Bake B., Oxelius V. A., Hanson L. A. Impaired lung function in patients with IgA deficiency and low levels of IgG2 or IgG3. N Engl J Med. 1985 Sep 19;313(12):720–724. doi: 10.1056/NEJM198509193131203. [DOI] [PubMed] [Google Scholar]
  10. Braun A., Kofler A., Morawietz S., Cleve H. Sequence and organization of the human vitamin D-binding protein gene. Biochim Biophys Acta. 1993 Dec 14;1216(3):385–394. doi: 10.1016/0167-4781(93)90005-x. [DOI] [PubMed] [Google Scholar]
  11. Buist A. S., Vollmer W. M., Wu Y., Tsai R., Johnson L. R., Hurd S., Davis C. E., Williams O. D., Li Y., Chen B. Effects of cigarette smoking on lung function in four population samples in the People's Republic of China. The PRC-US Cardiovascular and Cardiopulmonary Epidemiology Research Group. Am J Respir Crit Care Med. 1995 May;151(5):1393–1400. doi: 10.1164/ajrccm.151.5.7735591. [DOI] [PubMed] [Google Scholar]
  12. Buraczynska M., Schött D., Hanzlik A. J., Höltmann B., Ulmer W. T. Alpha 1-antitrypsin gene polymorphism related to respiratory system disease. Klin Wochenschr. 1987 Jul 15;65(12):538–541. doi: 10.1007/BF01727618. [DOI] [PubMed] [Google Scholar]
  13. Cantlay A. M., Lamb D., Gillooly M., Norrman J., Morrison D., Smith C. A., Harrison D. J. Association between the CYP1A1 gene polymorphism and susceptibility to emphysema and lung cancer. Clin Mol Pathol. 1995 Aug;48(4):M210–M214. doi: 10.1136/mp.48.4.m210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Cantlay A. M., Smith C. A., Wallace W. A., Yap P. L., Lamb D., Harrison D. J. Heterogeneous expression and polymorphic genotype of glutathione S-transferases in human lung. Thorax. 1994 Oct;49(10):1010–1014. doi: 10.1136/thx.49.10.1010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Cohen B. H., Bias W. B., Chase G. A., Diamond E. L., Graves C. G., Levy D. A., Menkes H., Meyer M. B., Permutt S., Tockman M. S. Is ABH nonsecretor status a risk factor for obstructive lung disease? Am J Epidemiol. 1980 Mar;111(3):285–291. doi: 10.1093/oxfordjournals.aje.a112898. [DOI] [PubMed] [Google Scholar]
  16. Cohen B. H., Diamond E. L., Graves C. G., Kreiss P., Levy D. A., Menkes H. A., Permutt S., Quaskey S., Tockman M. S. A common familial component in lung cancer and chronic obstructive pulmonary disease. Lancet. 1977 Sep 10;2(8037):523–526. doi: 10.1016/s0140-6736(77)90663-8. [DOI] [PubMed] [Google Scholar]
  17. Daniels S. E., Bhattacharrya S., James A., Leaves N. I., Young A., Hill M. R., Faux J. A., Ryan G. F., le Söuef P. N., Lathrop G. M. A genome-wide search for quantitative trait loci underlying asthma. Nature. 1996 Sep 19;383(6597):247–250. doi: 10.1038/383247a0. [DOI] [PubMed] [Google Scholar]
  18. Finkelstein R., Fraser R. S., Ghezzo H., Cosio M. G. Alveolar inflammation and its relation to emphysema in smokers. Am J Respir Crit Care Med. 1995 Nov;152(5 Pt 1):1666–1672. doi: 10.1164/ajrccm.152.5.7582312. [DOI] [PubMed] [Google Scholar]
  19. Finlay G. A., O'Driscoll L. R., Russell K. J., D'Arcy E. M., Masterson J. B., FitzGerald M. X., O'Connor C. M. Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. Am J Respir Crit Care Med. 1997 Jul;156(1):240–247. doi: 10.1164/ajrccm.156.1.9612018. [DOI] [PubMed] [Google Scholar]
  20. Finlay G. A., Russell K. J., McMahon K. J., D'arcy E. M., Masterson J. B., FitzGerald M. X., O'Connor C. M. Elevated levels of matrix metalloproteinases in bronchoalveolar lavage fluid of emphysematous patients. Thorax. 1997 Jun;52(6):502–506. doi: 10.1136/thx.52.6.502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Folz R. J., Peno-Green L., Crapo J. D. Identification of a homozygous missense mutation (Arg to Gly) in the critical binding region of the human EC-SOD gene (SOD3) and its association with dramatically increased serum enzyme levels. Hum Mol Genet. 1994 Dec;3(12):2251–2254. doi: 10.1093/hmg/3.12.2251. [DOI] [PubMed] [Google Scholar]
  22. Gasparini P., Savoia A., Luisetti M., Peona V., Pignatti P. F. The cystic fibrosis gene is not likely to be involved in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 1990 Mar;2(3):297–299. doi: 10.1165/ajrcmb/2.3.297. [DOI] [PubMed] [Google Scholar]
  23. Gelb A. F., Hogg J. C., Müller N. L., Schein M. J., Kuei J., Tashkin D. P., Epstein J. D., Kollin J., Green R. H., Zamel N. Contribution of emphysema and small airways in COPD. Chest. 1996 Feb;109(2):353–359. doi: 10.1378/chest.109.2.353. [DOI] [PubMed] [Google Scholar]
  24. Gelb A. F., Zamel N., Hogg J. C., Müller N. L., Schein M. J. Pseudophysiologic emphysema resulting from severe small-airways disease. Am J Respir Crit Care Med. 1998 Sep;158(3):815–819. doi: 10.1164/ajrccm.158.3.9801045. [DOI] [PubMed] [Google Scholar]
  25. Givelber R. J., Couropmitree N. N., Gottlieb D. J., Evans J. C., Levy D., Myers R. H., O'Connor G. T. Segregation analysis of pulmonary function among families in the Framingham Study. Am J Respir Crit Care Med. 1998 May;157(5 Pt 1):1445–1451. doi: 10.1164/ajrccm.157.5.9704021. [DOI] [PubMed] [Google Scholar]
  26. Haines A. P., Imeson J. D., Meade T. W. ABH secretor status and pulmonary function. Am J Epidemiol. 1982 Mar;115(3):367–370. doi: 10.1093/oxfordjournals.aje.a113314. [DOI] [PubMed] [Google Scholar]
  27. Hajeer A. H., Lazarus M., Turner D., Mageed R. A., Vencovsky J., Sinnott P., Hutchinson I. V., Ollier W. E. IL-10 gene promoter polymorphisms in rheumatoid arthritis. Scand J Rheumatol. 1998;27(2):142–145. doi: 10.1080/030097498441029. [DOI] [PubMed] [Google Scholar]
  28. Hankins D., Drage C., Zamel N., Kronenberg R. Pulmonary function in identical twins raised apart. Am Rev Respir Dis. 1982 Jan;125(1):119–121. doi: 10.1164/arrd.1982.125.3P2.119. [DOI] [PubMed] [Google Scholar]
  29. Harrison D. J., Cantlay A. M., Rae F., Lamb D., Smith C. A. Frequency of glutathione S-transferase M1 deletion in smokers with emphysema and lung cancer. Hum Exp Toxicol. 1997 Jul;16(7):356–360. doi: 10.1177/096032719701600703. [DOI] [PubMed] [Google Scholar]
  30. Hassett C., Aicher L., Sidhu J. S., Omiecinski C. J. Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum Mol Genet. 1994 Mar;3(3):421–428. doi: 10.1093/hmg/3.3.421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Hautamaki R. D., Kobayashi D. K., Senior R. M., Shapiro S. D. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science. 1997 Sep 26;277(5334):2002–2004. doi: 10.1126/science.277.5334.2002. [DOI] [PubMed] [Google Scholar]
  32. Higgins M. W., Keller J. B., Becker M., Howatt W., Landis J. R., Rotman H., Weg J. G., Higgins I. An index of risk for obstructive airways disease. Am Rev Respir Dis. 1982 Feb;125(2):144–151. doi: 10.1164/arrd.1982.125.2.144. [DOI] [PubMed] [Google Scholar]
  33. Higgins M., Keller J. Familial occurrence of chronic respiratory disease and familial resemblance in ventilatory capacity. J Chronic Dis. 1975 Apr;28(4):239–251. doi: 10.1016/0021-9681(75)90053-3. [DOI] [PubMed] [Google Scholar]
  34. Horne S. L., Cockcroft D. W., Dosman J. A. Possible protective effect against chronic obstructive airways disease by the GC2 allele. Hum Hered. 1990;40(3):173–176. doi: 10.1159/000153926. [DOI] [PubMed] [Google Scholar]
  35. Huang S. L., Su C. H., Chang S. C. Tumor necrosis factor-alpha gene polymorphism in chronic bronchitis. Am J Respir Crit Care Med. 1997 Nov;156(5):1436–1439. doi: 10.1164/ajrccm.156.5.9609138. [DOI] [PubMed] [Google Scholar]
  36. Hubbard R. C., Fells G., Gadek J., Pacholok S., Humes J., Crystal R. G. Neutrophil accumulation in the lung in alpha 1-antitrypsin deficiency. Spontaneous release of leukotriene B4 by alveolar macrophages. J Clin Invest. 1991 Sep;88(3):891–897. doi: 10.1172/JCI115391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. In K. H., Asano K., Beier D., Grobholz J., Finn P. W., Silverman E. K., Silverman E. S., Collins T., Fischer A. R., Keith T. P. Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription. J Clin Invest. 1997 Mar 1;99(5):1130–1137. doi: 10.1172/JCI119241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. James P. Protein identification in the post-genome era: the rapid rise of proteomics. Q Rev Biophys. 1997 Nov;30(4):279–331. doi: 10.1017/s0033583597003399. [DOI] [PubMed] [Google Scholar]
  39. Jeffery P. K. Structural and inflammatory changes in COPD: a comparison with asthma. Thorax. 1998 Feb;53(2):129–136. doi: 10.1136/thx.53.2.129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Kalsheker N. A., Morgan K. Regulation of the alpha 1-antitrypsin gene and a disease-associated mutation in a related enhancer sequence. Am J Respir Crit Care Med. 1994 Dec;150(6 Pt 2):S183–S189. doi: 10.1164/ajrccm/150.6_Pt_2.S183. [DOI] [PubMed] [Google Scholar]
  41. Kalsheker N., Morgan K. Molecular biology and respiratory disease. 7. The alpha 1 antitrypsin gene and chronic lung disease. Thorax. 1990 Oct;45(10):759–764. doi: 10.1136/thx.45.10.759. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Kauffmann F., Frette C., Pham Q. T., Nafissi S., Bertrand J. P., Oriol R. Associations of blood group-related antigens to FEV1, wheezing, and asthma. Am J Respir Crit Care Med. 1996 Jan;153(1):76–82. doi: 10.1164/ajrccm.153.1.8542166. [DOI] [PubMed] [Google Scholar]
  43. Kauffmann F., Kleisbauer J. P., Cambon-De-Mouzon A., Mercier P., Constans J., Blanc M., Rouch Y., Feingold N. Genetic markers in chronic air-flow limitation. A genetic epidemiologic study. Am Rev Respir Dis. 1983 Mar;127(3):263–269. doi: 10.1164/arrd.1983.127.3.263. [DOI] [PubMed] [Google Scholar]
  44. Keatings V. M., Barnes P. J. Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma, and normal subjects. Am J Respir Crit Care Med. 1997 Feb;155(2):449–453. doi: 10.1164/ajrccm.155.2.9032177. [DOI] [PubMed] [Google Scholar]
  45. Keatings V. M., Collins P. D., Scott D. M., Barnes P. J. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med. 1996 Feb;153(2):530–534. doi: 10.1164/ajrccm.153.2.8564092. [DOI] [PubMed] [Google Scholar]
  46. Khoury M. J., Beaty T. H., Newill C. A., Bryant S., Cohen B. H. Genetic-environmental interactions in chronic airways obstruction. Int J Epidemiol. 1986 Mar;15(1):65–72. doi: 10.1093/ije/15.1.65. [DOI] [PubMed] [Google Scholar]
  47. Kroeger K. M., Carville K. S., Abraham L. J. The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol. 1997 Apr;34(5):391–399. doi: 10.1016/s0161-5890(97)00052-7. [DOI] [PubMed] [Google Scholar]
  48. Krzyzanowski M., Jedrychowski W., Wysocki M. ABO blood group system and cigarette smoking: interaction in chronic airways obstruction. Int J Epidemiol. 1987 Jun;16(2):293–294. doi: 10.1093/ije/16.2.293. [DOI] [PubMed] [Google Scholar]
  49. Kueppers F., Miller R. D., Gordon H., Hepper N. G., Offord K. Familial prevalence of chronic obstructive pulmonary disease in a matched pair study. Am J Med. 1977 Sep;63(3):336–342. doi: 10.1016/0002-9343(77)90270-4. [DOI] [PubMed] [Google Scholar]
  50. Kuijpers A. L., Pfundt R., Zeeuwen P. L., Molhuizen H. O., Mariman E. C., van de Kerkhof P. C., Schalkwijk J. SKALP/elafin gene polymorphisms are not associated with pustular forms of psoriasis. Clin Genet. 1998 Jul;54(1):96–101. doi: 10.1111/j.1399-0004.1998.tb03703.x. [DOI] [PubMed] [Google Scholar]
  51. Lacraz S., Nicod L. P., Chicheportiche R., Welgus H. G., Dayer J. M. IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. J Clin Invest. 1995 Nov;96(5):2304–2310. doi: 10.1172/JCI118286. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Lim S., Crawley E., Woo P., Barnes P. J. Haplotype associated with low interleukin-10 production in patients with severe asthma. Lancet. 1998 Jul 11;352(9122):113–113. doi: 10.1016/S0140-6736(98)85018-6. [DOI] [PubMed] [Google Scholar]
  53. Lindmark B. E., Arborelius M., Jr, Eriksson S. G. Pulmonary function in middle-aged women with heterozygous deficiency of the serine protease inhibitor alpha 1-antichymotrypsin. Am Rev Respir Dis. 1990 Apr;141(4 Pt 1):884–888. doi: 10.1164/ajrccm/141.4_Pt_1.884. [DOI] [PubMed] [Google Scholar]
  54. Llewellyn-Jones C. G., Lomas D. A., Stockley R. A. Potential role of recombinant secretory leucoprotease inhibitor in the prevention of neutrophil mediated matrix degradation. Thorax. 1994 Jun;49(6):567–572. doi: 10.1136/thx.49.6.567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Lockhart D. J., Dong H., Byrne M. C., Follettie M. T., Gallo M. V., Chee M. S., Mittmann M., Wang C., Kobayashi M., Horton H. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol. 1996 Dec;14(13):1675–1680. doi: 10.1038/nbt1296-1675. [DOI] [PubMed] [Google Scholar]
  56. Louis E., Franchimont D., Piron A., Gevaert Y., Schaaf-Lafontaine N., Roland S., Mahieu P., Malaise M., De Groote D., Louis R. Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol. 1998 Sep;113(3):401–406. doi: 10.1046/j.1365-2249.1998.00662.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Luisetti M., Pignatti P. F. The search for susceptibility genes of COPD. Monaldi Arch Chest Dis. 1995 Jan;50(1):28–32. [PubMed] [Google Scholar]
  58. Luster A. D. Chemokines--chemotactic cytokines that mediate inflammation. N Engl J Med. 1998 Feb 12;338(7):436–445. doi: 10.1056/NEJM199802123380706. [DOI] [PubMed] [Google Scholar]
  59. Lüdecke B., Poller W., Olek K., Bartholomé K. Sequence variant of the human cathepsin G gene. Hum Genet. 1993 Mar;91(1):83–84. doi: 10.1007/BF00230230. [DOI] [PubMed] [Google Scholar]
  60. Mahadeva R., Lomas D. A. Genetics and respiratory disease. 2. Alpha 1-antitrypsin deficiency, cirrhosis and emphysema. Thorax. 1998 Jun;53(6):501–505. doi: 10.1136/thx.53.6.501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Marcus E. B., Buist A. S., Curb J. D., MacLean C. J., Reed D. M., Johnson L. R., Yano K. Correlates of FEV1 and prevalence of pulmonary conditions in Japanese-American men. Am Rev Respir Dis. 1988 Dec;138(6):1398–1404. doi: 10.1164/ajrccm/138.6.1398. [DOI] [PubMed] [Google Scholar]
  62. Metcalf J. P., Thompson A. B., Gossman G. L., Nelson K. J., Koyama S., Rennard S. I., Robbins R. A. Gcglobulin functions as a cochemotaxin in the lower respiratory tract. A potential mechanism for lung neutrophil recruitment in cigarette smokers. Am Rev Respir Dis. 1991 Apr;143(4 Pt 1):844–849. doi: 10.1164/ajrccm/143.4_Pt_1.844. [DOI] [PubMed] [Google Scholar]
  63. Moffatt M. F., Cookson W. O. Gene identification in asthma and allergy. Int Arch Allergy Immunol. 1998 Aug;116(4):247–252. doi: 10.1159/000023952. [DOI] [PubMed] [Google Scholar]
  64. O'Keeffe S., Gzel A., Drury R., Cullina M., Greally J., Finnegan P. Immunoglobulin G subclasses and spirometry in patients with chronic obstructive pulmonary disease. Eur Respir J. 1991 Sep;4(8):932–936. [PubMed] [Google Scholar]
  65. Oxelius V. A., Hanson L. A., Björkander J., Hammarström L., Sjöholm A. IgG3 deficiency: common in obstructive lung disease. Hereditary in families with immunodeficiency and autoimmune disease. Monogr Allergy. 1986;20:106–115. [PubMed] [Google Scholar]
  66. Pignatti P. F., Bombieri C., Marigo C., Benetazzo M., Luisetti M. Increased incidence of cystic fibrosis gene mutations in adults with disseminated bronchiectasis. Hum Mol Genet. 1995 Apr;4(4):635–639. doi: 10.1093/hmg/4.4.635. [DOI] [PubMed] [Google Scholar]
  67. Poller W., Faber J. P., Klobeck G., Olek K. Cloning of the human alpha 2-macroglobulin gene and detection of mutations in two functional domains: the bait region and the thiolester site. Hum Genet. 1992 Jan;88(3):313–319. doi: 10.1007/BF00197266. [DOI] [PubMed] [Google Scholar]
  68. Poller W., Faber J. P., Scholz S., Weidinger S., Bartholomé K., Olek K., Eriksson S. Mis-sense mutation of alpha 1-antichymotrypsin gene associated with chronic lung disease. Lancet. 1992 Jun 20;339(8808):1538–1538. doi: 10.1016/0140-6736(92)91301-n. [DOI] [PubMed] [Google Scholar]
  69. Poller W., Faber J. P., Weidinger S., Tief K., Scholz S., Fischer M., Olek K., Kirchgesser M., Heidtmann H. H. A leucine-to-proline substitution causes a defective alpha 1-antichymotrypsin allele associated with familial obstructive lung disease. Genomics. 1993 Sep;17(3):740–743. doi: 10.1006/geno.1993.1396. [DOI] [PubMed] [Google Scholar]
  70. Pride N. Smoking, allergy and airways obstruction: revival of the 'Dutch hypothesis'. Clin Allergy. 1986 Jan;16(1):3–6. doi: 10.1111/j.1365-2222.1986.tb01946.x. [DOI] [PubMed] [Google Scholar]
  71. Redline S., Tishler P. V., Lewitter F. I., Tager I. B., Munoz A., Speizer F. E. Assessment of genetic and nongenetic influences on pulmonary function. A twin study. Am Rev Respir Dis. 1987 Jan;135(1):217–222. doi: 10.1164/arrd.1987.135.1.217. [DOI] [PubMed] [Google Scholar]
  72. Repine J. E., Bast A., Lankhorst I. Oxidative stress in chronic obstructive pulmonary disease. Oxidative Stress Study Group. Am J Respir Crit Care Med. 1997 Aug;156(2 Pt 1):341–357. doi: 10.1164/ajrccm.156.2.9611013. [DOI] [PubMed] [Google Scholar]
  73. Rybicki B. A., Beaty T. H., Cohen B. H. Major genetic mechanisms in pulmonary function. J Clin Epidemiol. 1990;43(7):667–675. doi: 10.1016/0895-4356(90)90037-p. [DOI] [PubMed] [Google Scholar]
  74. Saetta M., Di Stefano A., Turato G., Facchini F. M., Corbino L., Mapp C. E., Maestrelli P., Ciaccia A., Fabbri L. M. CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 1):822–826. doi: 10.1164/ajrccm.157.3.9709027. [DOI] [PubMed] [Google Scholar]
  75. Sallenave J. M., Shulmann J., Crossley J., Jordana M., Gauldie J. Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes. Am J Respir Cell Mol Biol. 1994 Dec;11(6):733–741. doi: 10.1165/ajrcmb.11.6.7946401. [DOI] [PubMed] [Google Scholar]
  76. Sandford A. J., Chagani T., Weir T. D., Paré P. D. Alpha 1-antichymotrypsin mutations in patients with chronic obstructive pulmonary disease. Dis Markers. 1998 Feb;13(4):257–260. doi: 10.1155/1998/867620. [DOI] [PubMed] [Google Scholar]
  77. Sandford A. J., Spinelli J. J., Weir T. D., Paré P. D. Mutation in the 3' region of the alpha-1-antitrypsin gene and chronic obstructive pulmonary disease. J Med Genet. 1997 Oct;34(10):874–875. doi: 10.1136/jmg.34.10.874. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Sandford A. J., Weir T. D., Paré P. D. Genetic risk factors for chronic obstructive pulmonary disease. Eur Respir J. 1997 Jun;10(6):1380–1391. doi: 10.1183/09031936.97.10061380. [DOI] [PubMed] [Google Scholar]
  79. Sandford A., Weir T., Paré P. The genetics of asthma. Am J Respir Crit Care Med. 1996 Jun;153(6 Pt 1):1749–1765. doi: 10.1164/ajrccm.153.6.8665031. [DOI] [PubMed] [Google Scholar]
  80. Sandström J., Nilsson P., Karlsson K., Marklund S. L. 10-fold increase in human plasma extracellular superoxide dismutase content caused by a mutation in heparin-binding domain. J Biol Chem. 1994 Jul 22;269(29):19163–19166. [PubMed] [Google Scholar]
  81. Schellenberg D., Paré P. D., Weir T. D., Spinelli J. J., Walker B. A., Sandford A. J. Vitamin D binding protein variants and the risk of COPD. Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 1):957–961. doi: 10.1164/ajrccm.157.3.9706106. [DOI] [PubMed] [Google Scholar]
  82. Shapiro S. D. Elastolytic metalloproteinases produced by human mononuclear phagocytes. Potential roles in destructive lung disease. Am J Respir Crit Care Med. 1994 Dec;150(6 Pt 2):S160–S164. doi: 10.1164/ajrccm/150.6_Pt_2.S160. [DOI] [PubMed] [Google Scholar]
  83. Shapiro S. D., Kobayashi D. K., Ley T. J. Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages. J Biol Chem. 1993 Nov 15;268(32):23824–23829. [PubMed] [Google Scholar]
  84. Silverman E. K., Chapman H. A., Drazen J. M., Weiss S. T., Rosner B., Campbell E. J., O'DONNELL W. J., Reilly J. J., Ginns L., Mentzer S. Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis. Am J Respir Crit Care Med. 1998 Jun;157(6 Pt 1):1770–1778. doi: 10.1164/ajrccm.157.6.9706014. [DOI] [PubMed] [Google Scholar]
  85. Silverman E. K., Speizer F. E. Risk factors for the development of chronic obstructive pulmonary disease. Med Clin North Am. 1996 May;80(3):501–522. doi: 10.1016/s0025-7125(05)70451-x. [DOI] [PubMed] [Google Scholar]
  86. Smith C. A., Harrison D. J. Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet. 1997 Aug 30;350(9078):630–633. doi: 10.1016/S0140-6736(96)08061-0. [DOI] [PubMed] [Google Scholar]
  87. Stockley R. A. The role of proteinases in the pathogenesis of chronic bronchitis. Am J Respir Crit Care Med. 1994 Dec;150(6 Pt 2):S109–S113. doi: 10.1164/ajrccm/150.6_Pt_2.S109. [DOI] [PubMed] [Google Scholar]
  88. Stordeur P., Goldman M. Interleukin-10 as a regulatory cytokine induced by cellular stress: molecular aspects. Int Rev Immunol. 1998;16(5-6):501–522. doi: 10.3109/08830189809043006. [DOI] [PubMed] [Google Scholar]
  89. Tager I., Tishler P. V., Rosner B., Speizer F. E., Litt M. Studies of the familial aggregation of chronic bronchitis and obstructive airways disease. Int J Epidemiol. 1978 Mar;7(1):55–62. doi: 10.1093/ije/7.1.55. [DOI] [PubMed] [Google Scholar]
  90. Tashkin D. P., Altose M. D., Connett J. E., Kanner R. E., Lee W. W., Wise R. A. Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group. Am J Respir Crit Care Med. 1996 Jun;153(6 Pt 1):1802–1811. doi: 10.1164/ajrccm.153.6.8665038. [DOI] [PubMed] [Google Scholar]
  91. Tockman M. S., Anthonisen N. R., Wright E. C., Donithan M. G. Airways obstruction and the risk for lung cancer. Ann Intern Med. 1987 Apr;106(4):512–518. doi: 10.7326/0003-4819-106-4-512. [DOI] [PubMed] [Google Scholar]
  92. Turato G., Di Stefano A., Maestrelli P., Mapp C. E., Ruggieri M. P., Roggeri A., Fabbri L. M., Saetta M. Effect of smoking cessation on airway inflammation in chronic bronchitis. Am J Respir Crit Care Med. 1995 Oct;152(4 Pt 1):1262–1267. doi: 10.1164/ajrccm.152.4.7551380. [DOI] [PubMed] [Google Scholar]
  93. Turino G. M., Barker A. F., Brantly M. L., Cohen A. B., Connelly R. P., Crystal R. G., Eden E., Schluchter M. D., Stoller J. K. Clinical features of individuals with PI*SZ phenotype of alpha 1-antitrypsin deficiency. alpha 1-Antitrypsin Deficiency Registry Study Group. Am J Respir Crit Care Med. 1996 Dec;154(6 Pt 1):1718–1725. doi: 10.1164/ajrccm.154.6.8970361. [DOI] [PubMed] [Google Scholar]
  94. Turner D. M., Williams D. M., Sankaran D., Lazarus M., Sinnott P. J., Hutchinson I. V. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet. 1997 Feb;24(1):1–8. doi: 10.1111/j.1365-2370.1997.tb00001.x. [DOI] [PubMed] [Google Scholar]
  95. Vestbo J., Hein H. O., Suadicani P., Sørensen H., Gyntelberg F. Genetic markers for chronic bronchitis and peak expiratory flow in the Copenhagen Male Study. Dan Med Bull. 1993 Jun;40(3):378–380. [PubMed] [Google Scholar]
  96. Wallace R. W. DNA on a chip: serving up the genome for diagnostics and research. Mol Med Today. 1997 Sep;3(9):384–389. doi: 10.1016/S1357-4310(97)01097-6. [DOI] [PubMed] [Google Scholar]
  97. Webb D. R., Condemi J. J. Selective immunoglobulin A deficiency and chronic obstructive lung disease. A family study. Ann Intern Med. 1974 May;80(5):618–621. doi: 10.7326/0003-4819-80-5-618. [DOI] [PubMed] [Google Scholar]
  98. Webster P. M., Lorimer E. G., Man S. F., Woolf C. R., Zamel N. Pulmonary function in identical twins: comparison of nonsmokers and smokers. Am Rev Respir Dis. 1979 Feb;119(2):223–228. doi: 10.1164/arrd.1979.119.2.223. [DOI] [PubMed] [Google Scholar]
  99. White J. A., Petkovich M. Identification and cloning of RA-regulated genes by mRNA-differential display. Methods Mol Biol. 1998;89:389–404. doi: 10.1385/0-89603-438-0:389. [DOI] [PubMed] [Google Scholar]
  100. Wilson A. G., Symons J. A., McDowell T. L., McDevitt H. O., Duff G. W. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3195–3199. doi: 10.1073/pnas.94.7.3195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Yamamoto C., Yoneda T., Yoshikawa M., Fu A., Tokuyama T., Tsukaguchi K., Narita N. Airway inflammation in COPD assessed by sputum levels of interleukin-8. Chest. 1997 Aug;112(2):505–510. doi: 10.1378/chest.112.2.505. [DOI] [PubMed] [Google Scholar]
  102. Ye S., Watts G. F., Mandalia S., Humphries S. E., Henney A. M. Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis. Br Heart J. 1995 Mar;73(3):209–215. doi: 10.1136/hrt.73.3.209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. Zakrzewski J. T., Barnes N. C., Costello J. F., Piper P. J. Lipid mediators in cystic fibrosis and chronic obstructive pulmonary disease. Am Rev Respir Dis. 1987 Sep;136(3):779–782. doi: 10.1164/ajrccm/136.3.779. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES